Ethic Inc. Organon & Co. Transaction History

Ethic Inc.

$3.97 Billion
Q3 2024

A detailed history of Ethic Inc. transactions in Organon & Co. stock. As of the latest transaction made, Ethic Inc. holds 27,254 shares of OGN stock, worth $436,064. This represents 0.01% of its overall portfolio holdings.

Number of Shares

27,254

Previous 30,343 10.18%

Holding current value

$436,064

Previous $628,000 17.04%

% of portfolio

0.01%

Previous 0.01%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$18.65 - $23.03 $57,609 - $71,139	-3,089 Reduced 10.18%	27,254 $521,000
Q2 2024 Aug 13, 2024	BUY	$17.45 - $21.96 $53,903 - $67,834	3,089 Added 11.33%	30,343 $628,000
Q1 2024 May 13, 2024	BUY	$13.78 - $18.8 $51,344 - $70,048	3,726 Added 15.84%	27,254 $512,000
Q4 2023 Feb 14, 2024	BUY	$10.95 - $17.32 $124,402 - $196,772	11,361 Added 93.38%	23,528 $339,000
Q3 2023 Nov 14, 2023	SELL	$16.59 - $23.77 $432,766 - $620,064	-26,086 Reduced 68.19%	12,167 $211,000
Q2 2023 Aug 14, 2023	SELL	$19.27 - $24.63 $1,599 - $2,044	-83 Reduced 0.22%	38,253 $796,000
Q1 2023 May 12, 2023	BUY	$21.42 - $32.08 $140,172 - $209,931	6,544 Added 20.58%	38,336 $901,000
Q4 2022 Feb 14, 2023	BUY	$23.31 - $28.61 $326,316 - $400,511	13,999 Added 78.68%	31,792 $888,000
Q3 2022 Nov 14, 2022	BUY	$23.4 - $34.25 $154,557 - $226,221	6,605 Added 59.04%	17,793 $416,000
Q2 2022 Aug 10, 2022	BUY	$31.66 - $38.9 $110,588 - $135,877	3,493 Added 45.39%	11,188 $378,000
Q1 2022 May 16, 2022	BUY	$30.45 - $39.36 $234,312 - $302,875	7,695 New	7,695 $269,000

Others Institutions Holding OGN

# of Institutions

791

Shares Held

192M

Call Options Held

1.71M

Put Options Held

865K

View Full List

About Organon & Co.

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $4.07B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

More about OGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ethic Inc., based on Form 13F filings with the SEC.

News

Stay updated on Ethic Inc. with notifications on news.

Account